Early human trials of the EndoArt artificial corneal implant show it to be safe and effective in reducing corneal thickness without adverse events over 12 months. The device offers a simpler alternative to donor tissue transplants and may help address the global shortage of corneal grafts
© All rights reserved to EyeYon Medical